COMBIPHAR
Anastasya Ratu Chaerani is an experienced brand and product management professional with a strong background in the pharmaceutical and consumer health industries. Currently serving as Brand Manager at COMBIPHAR since October 2021, Anastasya leads brand planning and execution for the multivitamin and supplement category in the OTX channel. Prior experience includes roles as Senior Product Manager and Product Manager at Mega LifeSciences, where responsibilities encompassed creating consumer and trade programs for various products. Anastasya began a career at Novell Pharmaceutical Laboratories as a Product Executive, assisting in developing trade and consumer programs, and gained foundational experience in business development at PT. Galenium Pharmasia Laboratories, focusing on market analysis and consumer trends. Anastasya holds a Bachelor of Science degree in Biology from Universitas Padjadjaran, obtained in 2012.
This person is not in the org chart
COMBIPHAR
1 followers
Combiphar was founded in 1971 as a pharmaceutical company. Today, Combiphar is transforming into a modern consumer healthcare company that produces and markets more than 200 prescription and over-the-counter quality and affordable products, among others, OBH Combi cough syrup, Insto eye-care solution, JointFit gel-based relief for joints, CombiKid vitamin supplements, Privé green-tea based feminine hygiene wash, and Hezandra hepatoprotector supplement. Equipped with the latest production technology and the most up-to-date professional operation standards, Combiphar’s manufacturing plant, which is located in Padalarang, West Java, has most recently obtained the Therapeutic Goods Administration (TGA) Certification, allowing selected products to be exported to Australia. Additionally, Combiphar also has its own Research & Development facility, focusing on the quality optimization of prescription drugs to ensure that they meet the requirements of Bioavailability and Bioequivalence, as well as in the field of Nanotechnology. Combiphar has recently been ranked 2nd among local pharmaceutical companies recognized as “Indonesia’s Most Reputable Healthcare Brands 2015” (Onbee Research/SWA, May 2015) in terms of brand equity, customer loyalty, and customer experience.